Prosecution Insights
Last updated: April 19, 2026
Application No. 18/271,216

SENSOR APPARATUS WITH AN ACCELERATION SENSOR FOR MONITORING MOVEMENT AND TRANSMITTING DATA ON A MEDICAMENT CONTAINER, MONITORING SYSTEM AND MONITORING METHOD

Final Rejection §103
Filed
Jul 06, 2023
Examiner
DEAK, LESLIE R
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Ipb Intelligent Pill Box Ug (Haftungsbeschränkt)
OA Round
2 (Final)
75%
Grant Probability
Favorable
3-4
OA Rounds
3y 4m
To Grant
93%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allow Rate
693 granted / 924 resolved
+5.0% vs TC avg
Strong +18% interview lift
Without
With
+18.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
43 currently pending
Career history
967
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
47.9%
+7.9% vs TC avg
§102
25.1%
-14.9% vs TC avg
§112
11.4%
-28.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 924 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3, 6-12, 14, 16, 18, and 19 are rejected under 35 U.S.C. 103 as being unpatentable over WO 2020/106330 to Lebrun et al in view of Mayrhofer1. In the specification and figures, Lebrun discloses the apparatus substantially as claimed by Applicant. With regard to claims 1-3, 11, 16, 18, and 19, Lebrun discloses a sensor apparatus (smart cap) for attachment to a medicament container, wherein the cap comprises an accelerometer, an interface for wireless transmission to a computer (radio transmitter), and an electronic connection device (Bluetooth chip) (see ¶0004, 0016, 0018). Lebrun further discloses that the sensor may be configured to “wake up” based on an accelerometer signal to trigger communication between the sensor and the computing apparatus, but does not disclose an initial pairing via accelerometer (see ¶0016, 0098). Mayrhofer discloses an apparatus and method for using a pattern of movements from a device with an accelerometer to pair with a secondary device via construction of a shared key to authenticate the devices to communicate with one another (ShaCK method, see Abstract, §3.3). After the secure pairing, further data may be exchanged between the devices. The spontaneous pairing allows for the two devices to exchange information without prior knowledge of each other (see §1, Introduction). It would have been obvious to a person having ordinary skill in the art at the time of filing to use the pairing protocol and subsequent data exchange disclosed by Mayrhofer in the medicament container disclosed by Lebrun in order to create a pairing and communicate between two devices without prior knowledge of each other, as taught by Mayrhofer. With regard to claims 6-10, Lebrun discloses that a shaking motion may trigger a function (such as a refill request, missed dose, connection error, dose access event) other than connecting to a computer (see ¶0016, 0096, 0098, 0099). With regard to the recitations drawn to the number or temporal nature of the movements, such limitations are a recitation of the intended use of the claimed device. It has been held that a recitation with respect to the manner in which a claimed apparatus is intended to be employed does not differentiate the claimed apparatus from a prior art apparatus satisfying the claimed structural limitations. See MPEP § 2114. With regard to claim 12, Lebrun discloses that an alarm may be used to trigger audio and visual cues between the packaging and a remote computer (see at least ¶0063, 0067). With regard to claim 14, Lebrun discloses that the sensor apparatus may comprise a memory to store movement records (see ¶0016, 0017). With regard to claims 25, 27, see the rejection of claims 4-10 above. Lebrun further discloses providing a text message or haptic feedback to a user (see ¶0096, 0098). With regard to claim 35, Applicant discloses that the retrofit kit comprises an accelerometer and a computer monitor, both of which are disclosed by Lebrun (see ¶0016, 0017). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LESLIE R DEAK whose telephone number is (571)272-4943. The examiner can normally be reached Monday-Friday, 9am to 5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at 571-272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LESLIE R DEAK/Primary Examiner, Art Unit 3799 5 February 2026 1 R. Mayrhofer and H. Gellersen, "Shake Well Before Use: Intuitive and Secure Pairing of Mobile Devices," in IEEE Transactions on Mobile Computing, vol. 8, no. 6, pp. 792-806, June 2009, doi: 10.1109/TMC.2009.51.
Read full office action

Prosecution Timeline

Jul 06, 2023
Application Filed
Jul 11, 2025
Non-Final Rejection — §103
Dec 29, 2025
Response Filed
Feb 05, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599497
IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
2y 5m to grant Granted Apr 14, 2026
Patent 12594186
AQUEOUS HUMOR DRAINAGE DEVICE WITH ADJUSTABLE TUBE DIAMETER
2y 5m to grant Granted Apr 07, 2026
Patent 12575972
GLAUCOMA STENT AND METHODS THEREOF FOR GLAUCOMA TREATMENT
2y 5m to grant Granted Mar 17, 2026
Patent 12569604
METHOD AND DEVICES FOR DETERMINING A TIME POINT FOR MEASURING PRESSURE MEASUREMENTS
2y 5m to grant Granted Mar 10, 2026
Patent 12569654
SYSTEMS AND METHODS FOR TREATMENT OF FLUID OVERLOAD
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
75%
Grant Probability
93%
With Interview (+18.0%)
3y 4m
Median Time to Grant
Moderate
PTA Risk
Based on 924 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month